For Immediate Release
Contact: Rob Grant, Communications Director
202.966.7300, Ext. 119
Caitlyn Camacho, Communications & Marketing Coordinator
202.966.7300, Ext. 154
Washington, D.C., August 5, 2013 - The American Academy of Child and Adolescent Psychiatry (AACAP) proudly presents its newly revised medication guide for parents on treating Attention-Deficit/Hyperactivity Disorder (ADHD).
Updates to the guide include the addition of new research about children with ADHD in school, the transition of adolescents with ADHD into college and adulthood, and more effective treatments.
“We hope this Guide will aid families to better understand the advances being made in ADHD and its treatment, and to serve as a useful tool for clinicians caring for individuals with this disorder,” said Theodore Petti, M.D., medication guide workgroup chair.
The guide was revised by a workgroup from AACAP including contributions from the American Psychiatric Association (APA), the American Academy of Pediatrics (AAP), Children and Adults with Attention-Deﬁcit/Hyperactivity Disorder (CHADD) and the National Alliance on Mental Illness (NAMI).
The guide is a revision of the original 2007 ADHD Parents Medication Guide, which is was a joint project of AACAP and the APA, funded by the Elaine Schlosser Lewis Fund.
Click here to access the guide.
To learn more about AACAP’s efforts or to speak with an expert, please contact Caitlyn Camacho, Communications Coordinator, at 202.966.7300, ext. 154 or email@example.com.
Representing over 8,500 child and adolescent psychiatrists nationwide, the American Academy of Child and Adolescent Psychiatry (AACAP) is the leading authority on children's mental health.
AACAP Members actively research, diagnose and treat psychiatric disorders affecting children, adolescents and their families. For more information please visit www.aacap.org.